Viral envelope fails to deliver?

Nature

Volumn 391, Issue 6668, 1998, Pages 638-639

  Bolognesi, Dani P ^a   Matthews, Thomas J ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; ANTIGEN; CARBOHYDRATE; CD4 ANTIGEN; ENVELOPE PROTEIN; GLYCOPROTEIN GP 120; HUMAN IMMUNODEFICIENCY VIRUS VACCINE; NEUTRALIZING ANTIBODY; RECEPTOR; VIRUS GLYCOPROTEIN; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; RECOMBINANT VACCINE;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ANTIBODY RESPONSE; CLINICAL TRIAL; DRUG SAFETY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; IMMUNOGENICITY; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; TREATMENT FAILURE; VACCINATION; VIRUS ENVELOPE; VIRUS IMMUNITY; VIRUS INFECTIVITY; ARTICLE; CYTOTOXIC T LYMPHOCYTE; IMMUNOLOGY; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; THAILAND; UNITED STATES;

AIDS VACCINES; CLINICAL TRIALS, PHASE I; CLINICAL TRIALS, PHASE II; HIV; HIV ANTIBODIES; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HUMANS; T-LYMPHOCYTES, CYTOTOXIC; THAILAND; UNITED STATES; VACCINES, SYNTHETIC;

EID: 0032509888     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/35504     Document Type: Short Survey

References (10)

1. Cohen, J. Science 254, 1839 (1994).
2. McElrath, J. et al. Proc. Natl Acad. Sci. USA 93, 3972-3977 (1996).
3. Connor, R. I. et al. J. Virol. 72, 1552-1576 (1998).
4. Kahn, J. et al. J. Infect. Dis. 171, 1343-1347 (1995).
5. Berman, P. et al. J. Infect. Dis, 176, 384-397 (1997).
6. Graham, B. et al. J. Infect. Dis. 177, 310-319 (1998).
7. Matthews, T. AIDS Res. Hum. Retroviruses 10, 631-632 (1994).
8. Crey, L. et al. 4th Conf. Retroviruses Opportunistic Infect. (in the press).
9. Ferrari, G. et al. Proc. Natl Acad. Sci. USA 94, 1396-1401 (1997).
10. Rosenberg, E. et al. Science 21, 1447-1450 (1997).